1. Yu, L. X., Amidon, G., Khan, M. A., Hoag, S. W., Polli, J., Raju, G. K., et al. (2014). Understanding pharmaceutical quality by design. The AAPS Journal, 16(4), 771–783. https://doi.org/10.1208/s12248-014-9598-3
2. Uner, B. D. P., & Baranauskaite, J. (2022). Ocular delivery systems and applications developed by QbD perspective: From the past to the future. In H. Kafadar (Ed.), Multidisciplinary approach in medical science II (pp. 49–63). IKSAD Publishing House.
3. Administration USFaD. (1995). Guidance for industry: immediate release solid oral dosage forms scale-up and postapproval changes: chemistry, manufacturing, and controls, in vitro dissolution testing, and in vivo bioequivalence documentation. Retrived June 21, 2023
4. CDER USFaDA. (2004). PAT—a framework for innovative pharmaceutical development, manufacturing, and quality assurance. Guidance for industry. CDER USFaDA.
5. ICH. (2005). Guideline: validation of analytical procedures: Textand methodology Q2 (R1). Harmonization ICo E.